EverHint Signal — Momentum Swing: Breakout Standard — November 21, 2025

What This Signal Is (Quick)

Breakout Standard is an experimental momentum swing scanner that looks for stocks sitting within roughly 3% of their 52-week highs, backed by expanding volume and persistent upside momentum. The idea: catch “standard” breakouts or tight consolidations just below new highs, where institutional demand often builds before the next leg up.

This setup is designed for 1–4 week swing trades, not intraday scalps or long-term investing. It focuses on:

• Price hugging or tagging 52-week highs
• Volume thrust (today’s volume vs 20-day average) as a proxy for institutional interest
• Trend structure vs key moving averages (10/21/50/200-day)
• A composite score (0–1) that blends momentum, trend strength and liquidity into a single quality rank

Because it’s a systematic, rules-based screen, it will surface both familiar blue chips and lesser-known names. Some will go on to trend nicely; others will fail quickly. That’s why this remains an experimental scanner for education, research and back-testing—not a buy list or financial advice.

How We Ranked Today (Reader Version)

For today’s Breakout Standard list (11 symbols), we ranked candidates by their composite quality score, converted to a 0–100 scale for readability.

• Primary rank:
  • Score (0–100) – higher = stronger overall quality in this breakout framework
• Context overlays:
  • Volume Thrust – how many times above/below the 20-day average volume
  • % of 52-Week High – how tight the stock sits to its yearly high
  • Insider Net (USD) – net open-market buying/selling over the last ~90 days (P vs S transactions only)
  • Days → Earnings – calendar distance from today’s signal to the next earnings date

When RSI data is available for a strategy, the default is to rank by RSI; for today’s run, we lean on the composite score because it’s specifically tuned to this breakout variant and gives a cleaner quality stack for readers.

Signals are best treated as starting points for your own research, position sizing and risk management—not as trade instructions.

🚀 Breakout Signals – November 21, 2025 (Ranked by Score)

How to read the table (quick):

• Vol Thrust:
  • ~1.5–2.0x = solid confirmation of interest
  • 2.5–3.0x+ = aggressive participation / possible chase
  • NVRI stands out with ~6.8x, an outlier surge in liquidity
• % of 52W High:
  • 100% = basically at the 52-week high
  • High-90s = tight consolidation just under new highs
  • GAP is the only name notably below, ~86%, more of a recovery breakout than a pure high-base
• Insider Net (USD):
  • Negative values (e.g., NTRA, GCT, GAP) reflect net open-market selling in recent filings
  • Absence of data simply means there’s no notable net P/S activity in the recent window, not that insiders did nothing
• Days → Earnings:
  • 60–90 days out (BKD, MRK, HCA, AZN, IDXX, MTD, NVRI) = earnings risk is there, but not imminent
  • Empty cells = no upcoming earnings date in the current window

Recent Headlines – What Might Be Driving Some Moves

This section highlights a few notable headlines around today’s higher-ranked or more active signals, using recent public news flow as context rather than as a trading signal.

• AZN — AstraZeneca PLC
  • Announced plans to invest about $2 billion into new manufacturing capacity in the US, underscoring long-term growth and presence in key markets.
  • Secured FDA approvals for expanded indications in rare-disease and oncology-adjacent segments, reinforcing the pipeline narrative behind the breakout.
  • Several outlets framed the stock’s move as a response to both the capex commitment and positive regulatory news, fitting well with a breakout at fresh highs.
• BKD — Brookdale Senior Living Inc.
  • Announced a new Chief Operating Officer with roughly four decades of experience in senior living operations.
  • Market reaction suggests investors see the leadership update as supportive of execution at a time when the stock is pressing new highs, backed by a near-2.0x volume thrust.
• GAP — The Gap, Inc.
  • The stock has been in a strong recovery trend in recent months, and today’s screening shows it still carrying 2.4x volume thrust while sitting just under prior 52-week highs.
  • Recent commentary has focused on ongoing brand refresh efforts and margin stabilization; today’s price/volume action is consistent with continued re-rating rather than early-stage breakout.
• GCT / EXAS / NTRA
  • These names combine strong price action at or near highs with healthy liquidity and, in some cases, meaningful insider selling (especially NTRA and GCT).
  • In high-beta, high-growth stories, insider selling doesn’t automatically negate the trend, but it can matter for risk management and conviction sizing.

News is provided as context only and may lag intraday moves. Always read the full articles and cross-check before drawing conclusions.

Field Notes – What Stands Out in Today’s List

• Healthcare dominates the tape
  • 8 out of 11 signals are in Healthcare, spanning big pharma (MRK, AZN), managed care/hospital operators (HCA), diagnostics (EXAS, IDXX), precision medicine/genomics (NTRA), and analytic equipment (MTD).
  • That clustering suggests a sector-level bid under healthcare growth and quality names, consistent with money rotating into relatively defensive but still growth-oriented stories.
• Classic high-base breakouts vs “catch-up” plays
  • Names like MRK, AZN, HCA, IDXX, MTD are pinned right at 52-week highs with steady, not explosive, volume thrust—this is textbook high-base breakout behavior.
  • GAP sits materially below its high (~86%), more like a trend continuation after a deep recovery, where swings can be wider but reward can also be substantial.
• Outlier liquidity: NVRI (Enviri)
  • NVRI’s 6.8x volume thrust stands out. That’s often what you see when a smaller industrial name gets discovered by a new class of buyers or responds to a catalyst (earnings update, guidance, or corporate action).
  • At the same time, its market cap (~$1.4B) and industrial niche mean volatility can be higher and spreads wider than in mega-caps.
• Insider flows skew mildly negative in several leaders
  • NTRA, GCT, GAP, HCA, IDXX, EXAS all show net open-market insider selling over the recent window.
  • That doesn’t invalidate the breakout, but it does argue for more conservative sizing and tighter invalidation levels if you’re trading around these names.
• Earnings calendar not immediately pressing
  • Most covered names have earnings 60–90 days out. This is comfortable for a 1–4 week swing lens, but it’s still worth mapping your holding window vs those dates if you don’t like holding through prints.

Overall, this run of Breakout Standard looks like a healthcare-heavy, quality-tilted momentum list with a couple of higher-beta satellite plays (NVRI, GCT, GAP).

Vlad’s Take (EverHint)

Today’s market backdrop tilted risk-on with a cautious overlay:

• The S&P 500 gained about 0.7%, the Nasdaq Composite roughly 0.5%, and the Dow almost 1.0%, pointing to broad strength with a slight tilt toward blue-chips.
• Small-caps ripped higher: the Russell 2000 was up around 2.7%, which is exactly the kind of move you like to see when scouting breakout and momentum setups.
• The VIX closed near 23, down almost 10% on the day—still an elevated volatility regime, but clearly easing rather than spiking.
• On the macro side, the 10-Year Treasury yield slipped slightly, which tends to be constructive for growth and higher-duration equities, while Bitcoin and Ethereum both traded lower, hinting at some profit-taking on the speculative side of the risk spectrum.

In that environment, a breakout-heavy screen like this is more actionable than on a day when indices are red and volatility is spiking. That said, a VIX in the low-20s is not a “complacent” regime; it still argues for respecting risk:

• Consider tiered entries (e.g., partial positions) rather than all-in orders at the high of day.
• For names with heavy insider selling (NTRA, GCT, GAP), be more demanding on your entry and stop placement.
• With so many healthcare names clustered at the top of the list, watch for sector-wide pullbacks that could drag them together, regardless of individual stories.

As always, this Breakout Standard scan is experimental and meant for market research and idea discovery, not trade alerts. Treat it as a structured watchlist that you stress-test against your own process.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/.